Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection

Vaccine

Volumn 30, Issue 46, 2012, Pages 6588-6594

  Monney, Thierry ^a   Debache, Karim ^a   Grandgirard, Denis ^a   Leib, Stephen L ^a   Hemphill, Andrew ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chimeric vaccine; Neospora caninum; Neosporosis; Pregnant mouse; Recombinant antigen

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G1; INTERLEUKIN 4; RECOMBINANT ANTIGEN; RECOMBINANT CHIMERIC ANTIGEN RECNCMIC3 1 R; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NEOSPOROSIS; NONHUMAN; PREDICTION; PREGNANCY; PRIORITY JOURNAL; SEROLOGY; TACHYZOITE; TH1 CELL; TH2 CELL; VACCINATION; VERTICAL TRANSMISSION;

ANIMALS; ANTIGENS, PROTOZOAN; COCCIDIOSIS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; NEOSPORA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROTOZOAN VACCINES; TH2 CELLS; VACCINATION; VACCINES, SYNTHETIC;

EID: 84866995367     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.024     Document Type: Article

References (50)

1. Dubey J.P., Schares G., Ortega-Mora L.M. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 2007, 20(2):323-367.
2. Hemphill A., Gottstein B. A European perspective on Neospora caninum. Int J Parasitol 2000, 30(8):877-924.
3. Dubey J.P., Schares G. Neosporosis in animals - the last five years. Vet Parasitol 2011, 180(1-2):90-108.
4. Williams D.J., Hartley C.S., Bjorkman C., Trees A.J. Endogenous and exogenous transplacental transmission of Neospora caninum - how the route of transmission impacts on epidemiology and control of disease. Parasitology 2009, 136(14):1895-1900.
5. Davison H.C., Otter A., Trees A.J. Estimation of vertical and horizontal transmission parameters of Neospora caninum infections in dairy cattle. Int J Parasitol 1999, 29(10):1683-1689.
6. Reichel M.P., Ellis J.T. If control of Neospora caninum infection is technically feasible does it make economic sense?. Vet Parasitol 2006, 142(1-2):23-34.
7. Reichel M.P., Ellis J.T. Re-evaluating the economics of neosporosis control. Vet Parasitol 2008, 156(3-4):361-362.
8. Innes E.A., Bartley P.M., Maley S.W., Wright S.E., Buxton D. Comparative host-parasite relationships in ovine toxoplasmosis and bovine neosporosis and strategies for vaccination. Vaccine 2007, 25(30):5495-5503.
9. Williams D.J., Trees A.J. Protecting babies: vaccine strategies to prevent foetopathy in Neospora caninum-infected cattle. Parasite Immunol 2006, 28(3):61-67.
10. Reichel M.P., Ellis J.T. Neospora caninum - how close are we to development of an efficacious vaccine that prevents abortion in cattle?. Int J Parasitol 2009, 39(11):1173-1187.
11. Romero J.J., Perez E., Frankena K. Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Vet Parasitol 2004, 123(3-4):149-159.
12. Weston J.F., Heuer C., Williamson N.B. Efficacy of a Neospora caninum killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle. Prev Vet Med 2011, 103(2-3):136-144.
13. Hemphill A., Vonlaufen N., Naguleswaran A. Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology 2006, 133(Pt 3):261-278.
14. Innes E.A. The host-parasite relationship in pregnant cattle infected with Neospora caninum. Parasitology 2007, 134(Pt 13):1903-1910.
15. Monney T., Debache K., Hemphill A. Vaccines against a major cause of abortion in cattle, Neospora caninum infection. Animals 2011, 1(3):306-325.
16. Alaeddine F., Keller N., Leepin A., Hemphill A. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J Parasitol 2005, 91(3):657-665.
17. Cannas A., Naguleswaran A., Muller N., Gottstein B., Hemphill A. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol 2003, 89(1):44-50.
18. Debache K., Guionaud C., Alaeddine F., Mevissen M., Hemphill A. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Int J Parasitol 2008, 38(12):1455-1463.
19. Debache K., Alaeddine F., Guionaud C., Monney T., Muller J., Strohbusch M., et al. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int J Parasitol 2009, 39:1373-1384.
20. Monney T., Rutti D., Schorer M., Debache K., Grandgirard D., Leib S.L., et al. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection. Vaccine 2011, 29(40):6967-6975.
21. Dubey J.P., Hattel A.L., Lindsay D.S., Topper M.J. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc 1988, 193(10):1259-1263.
22. Hemphill A., Gottstein B., Kaufmann H. Adhesion and invasion of bovine endothelial cells by Neospora caninum. Parasitology 1996, 112(Pt 2):183-197.
23. Whitten M.K. Effect of exteroceptive factors on the oestrous cycle of mice. Nature 1957, 180(4599):1436.
24. Müller N., Vonlaufen N., Gianinazzi C., Leib S.L., Hemphill A. Application of real-time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous system tissue. J Clin Microbiol 2002, 40(1):252-255.
25. Miller C., Quinn H., Ryce C., Reichel M.P., Ellis J.T. Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination. Int J Parasitol 2005, 35(7):821-828.
26. Williams D.J., Guy C.S., Smith R.F., Ellis J., Bjorkman C., Reichel M.P., et al. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Infect Immun 2007, 75(3):1343-1348.
27. Marugan-Hernandez V., Ortega-Mora L.M., Aguado-Martinez A., Jimenez-Ruiz E., Alvarez-Garcia G. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice. Vaccine 2011, 29(44):7867-7874.
28. Liddell S., Jenkins M.C., Collica C.M., Dubey J.P. Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J Parasitol 1999, 85(6):1072-1075.
29. Rojo-Montejo S., Collantes-Fernandez E., Rodriguez-Marcos S., Perez-Zaballos F., Lopez-Perez I., Prenafeta A., et al. Comparative efficacy of immunization with inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against neosporosis in mice. Parasitology 2011, 138(11):1372-1383.
30. Kano R., Masukata Y., Omata Y., Kobayashi Y., Maeda R., Saito A. Relationship between type 1/type 2 immune responses and occurrence of vertical transmission in BALB/c mice infected with Neospora caninum. Vet Parasitol 2005, 129(1-2):159-164.
31. Quinn H.E., Miller C.M.D., Ellis J.T. The cell-mediated immune response to Neospora caninum during pregnancy in the mouse is associated with a bias towards production of interleukin-4. Int J Parasitol 2004, 34(6):723-732.
32. Debache K., Kropf C., Schutz C.A., Harwood L.J., Kauper P., Monney T., et al. Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites. Parasite Immunol 2011, 33(2):81-94.
33. Bartley P.M., Wright S.E., Maley S.W., Buxton D., Nath M., Innes E.A. The development of immune responses in Balb/c mice following inoculation with attenuated or virulent Neospora caninum tachyzoites. Parasite Immunol 2009, 31(7):392-401.
34. Nishikawa Y., Inoue N., Makala L., Nagasawa H. A role for balance of interferon-gamma and interleukin-4 production in protective immunity against Neospora caninum infection. Vet Parasitol 2003, 116(3):175-184.
35. Beagley K.W., Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38(1):13-22.
36. Klevar S., Kulberg S., Boysen P., Storset A.K., Moldal T., Bjorkman C., et al. Natural killer cells act as early responders in an experimental infection with Neospora caninum in calves. Int J Parasitol 2007, 37(3-4):329-339.
37. Debache K., Guionaud C., Alaeddine F., Hemphill A. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites. Parasitology 2010, 137(2):229-240.
38. Haldorson G.J., Mathison B.A., Wenberg K., Conrad P.A., Dubey J.P., Trees A.J., et al. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Int J Parasitol 2005, 35(13):1407-1415.
39. Quinn H.E., Ellis J.T., Smith N.C. Neospora caninum: a cause of immune-mediated failure of pregnancy?. Trends Parasitol 2002, 18(9):391-394.
40. Rosbottom A., Gibney E.H., Guy C.S., Kipar A., Smith R.F., Kaiser P., et al. Upregulation of cytokines is detected in the placentas of cattle infected with Neospora caninum and is more marked early in gestation when fetal death is observed. Infect Immun 2008, 76(6):2352-2361.
41. Aguado-Martinez A., Alvarez-Garcia G., Fernandez-Garcia A., Risco-Castillo V., Marugan-Hernandez V., Ortega-Mora L.M. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice. Vaccine 2009, 27(52):7331-7338.
42. Ribeiro D.P., Freitas M.M., Cardoso M.R., Pajuaba A.C., Silva N.M., Mineo T.W., et al. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice. Vaccine 2009, 27(19):2570-2579.
43. Baszler T.V., McElwain T.F., Mathison B.A. Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease. Clin Diagn Lab Immunol 2000, 7(6):893-898.
44. Long M.T., Baszler T.V., Mathison B.A. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. J Parasitol 1998, 84(2):316-320.
45. Rojo-Montejo S., Collantes-Fernandez E., Regidor-Cerrillo J., Rodriguez-Bertos A., Prenafeta A., Gomez-Bautista M., et al. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice. Vet Parasitol 2011, 175(3-4):220-229.
46. Strohbusch M., Muller N., Hemphill A., Margos M., Grandgirard D., Leib S., et al. Neospora caninum and bone marrow-derived dendritic cells: parasite survival, proliferation, and induction of cytokine expression. Parasite Immunol 2009, 31(7):366-372.
47. Feng X., Zhang N., Tuo W. Neospora caninum tachyzoite- and antigen-stimulated cytokine production by bone marrow-derived dendritic cells and spleen cells of naive BALB/c mice. J Parasitol 2010, 96(4):717-723.
48. Penarete-Vargas D.M., Mevelec M.N., Dion S., Seche E., Dimier-Poisson I., Fandeur T. Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain. Infect Immun 2010, 78(2):651-660.
49. Dion S., Germon S., Guiton R., Ducournau C., Dimier-Poisson I. Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninum. Int J Parasitol 2011, 41(6):685-695.
50. Ellis J., Miller C., Quinn H., Ryce C., Reichel M.P. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine 2008, 26(47):5989-5996.